DMS PHARMACEUTICAL GROUP INC. recorded $1,870,331,518.59 in obligated federal awards across 305,715 actions in the last 10 years, with an average action value of $6,117.89. Most activity came from the Defense Logistics Agency, and the largest NAICS categories were drugs and druggists' sundries merchant wholesalers, medicinal and botanical manufacturing, and pharmaceutical preparation manufacturing.
Federal Contractor
DMS PHARMACEUTICAL GROUP INC. Federal Contract Obligations (Last 10 Years)
Federal procurement profile for DMS PHARMACEUTICAL GROUP INC. (CAGE 1UNB0, UEI PX72BSBQTKJ3) covering obligations, agencies, NAICS, and annual award trends over the last 10 years.
Annual totals remain concentrated in the 2021-2025 period, with obligations ranging from $247.29 million to $283.98 million and no inferred values beyond the provided FPDS data.
CAGE Code
1UNB0
UEI
PX72BSBQTKJ3
Total Obligated
1.87 billion
1,870,331,518.59
Award Actions
305,715
Average Action Value
6,117.89
About DMS PHARMACEUTICAL GROUP INC. federal contract activity
DMS PHARMACEUTICAL GROUP INC. (CAGE 1UNB0, UEI PX72BSBQTKJ3) recorded $1.87 billion in obligated federal awards across 305,715 actions over the last 10 years, with an average award value of $6,117.89. The profile is highly transaction-heavy, indicating sustained participation in high-volume procurement rather than dependence on a small number of large awards.
Agency mix and customer concentration
The award base is overwhelmingly concentrated in the Defense Logistics Agency, which accounts for $1.86 billion and 305,569 awards, or nearly the entire observed obligation total. The only other material customer is the Department of Veterans Affairs at $10.90 million across 136 awards, while all remaining agencies together contribute only marginal activity.
Industry profile based on NAICS activity
The vendor’s obligations are led by NAICS 424210, Drugs and Druggists' Sundries Merchant Wholesalers, at $1.44 billion across 146,411 awards. Additional volume is concentrated in medicinal and botanical manufacturing (325411) and pharmaceutical preparation manufacturing (325412), with smaller activity in in-vitro diagnostic substance manufacturing (325413) and medical, dental, and hospital equipment and supplies wholesaling (423450).
Annual contract trend over the analysis window
Annual obligations have remained relatively stable in the mid-$200 million range over the most recent five years shown, ranging from $247.29 million in 2021 to $283.98 million in 2025. Award counts have also stayed high and consistent, suggesting a durable recurring supply relationship rather than volatile, project-based demand.
How to interpret this page
This summary is based on FPDS award-obligation data for the last 10 years and aggregates totals by vendor, agency, NAICS code, and year. Amounts reflect obligated dollars and award counts as reported in the analysis window; no outside data or assumptions were added.
Top Agencies
SELECT
agency_id,
agency_name,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
content__award__purchaserInformation__contractingOfficeAgencyID AS agency_id,
anyHeavy(content__award__purchaserInformation__contractingOfficeAgencyID__name) AS agency_name,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '1UNB0'
AND content__award__purchaserInformation__contractingOfficeAgencyID IS NOT NULL
AND content__award__purchaserInformation__contractingOfficeAgencyID != ''
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 10 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY agency_id
)
ORDER BY total_obligated DESC
LIMIT 10| Agency ID | Agency Name | Total Obligated | Readable | Award Actions |
|---|---|---|---|---|
| 97AS | DEFENSE LOGISTICS AGENCY | 1,859,354,167.72 | 1.86 billion | 305,569 |
| 3600 | VETERANS AFFAIRS, DEPARTMENT OF | 10,904,786.64 | 10.90 million | 136 |
| 7014 | U.S. CUSTOMS AND BORDER PROTECTION | 49,031.40 | 49.03 thousand | 1 |
| 2100 | DEPT OF THE ARMY | 19,486.97 | 19.49 thousand | 4 |
| 7524 | FOOD AND DRUG ADMINISTRATION | 9,385.88 | 9.39 thousand | 1 |
| 7523 | CENTERS FOR DISEASE CONTROL AND PREVENTION | 0.00 | 0.00 | 2 |
| 7529 | NATIONAL INSTITUTES OF HEALTH | -5,340.02 | -5.34 thousand | 2 |
Insight
DMS PHARMACEUTICAL GROUP INC.’s FPDS obligations over the last 10 years are overwhelmingly concentrated at the Defense Logistics Agency, which accounts for $1.86 billion of the firm’s $1.87 billion total and 305,569 of 305,715 awards. The Department of Veterans Affairs is a distant second at $10.90 million across 136 awards, while all other agencies represent only de minimis activity. Outside DLA and VA, agency obligations are negligible, including isolated awards to CBP, the Army, FDA, CDC, and NIH, with CDC at $0 and NIH showing a net negative obligated amount.
Top NAICS
SELECT
naics_code,
naics_name,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
content__award__productOrServiceInformation__principalNAICSCode AS naics_code,
anyHeavy(content__award__productOrServiceInformation__principalNAICSCode__description) AS naics_name,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '1UNB0'
AND content__award__productOrServiceInformation__principalNAICSCode IS NOT NULL
AND content__award__productOrServiceInformation__principalNAICSCode != ''
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 10 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY naics_code
)
ORDER BY total_obligated DESC
LIMIT 10| NAICS Code | Description | Total Obligated | Readable | Award Actions |
|---|---|---|---|---|
| 424210 | DRUGS AND DRUGGISTS' SUNDRIES MERCHANT WHOLESALERS | 1,438,890,395.03 | 1.44 billion | 146,411 |
| 325411 | MEDICINAL AND BOTANICAL MANUFACTURING | 383,838,484.76 | 383.84 million | 87,843 |
| 325412 | PHARMACEUTICAL PREPARATION MANUFACTURING | 35,828,080.89 | 35.83 million | 66,174 |
| 325413 | IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING | 6,553,735.94 | 6.55 million | 43 |
| 423450 | MEDICAL, DENTAL, AND HOSPITAL EQUIPMENT AND SUPPLIES MERCHANT WHOLESALERS | 5,146,675.64 | 5.15 million | 5,192 |
| 456199 | ALL OTHER HEALTH AND PERSONAL CARE RETAILERS | 27,118.12 | 27.12 thousand | 20 |
| 446199 | ALL OTHER HEALTH AND PERSONAL CARE STORES | 25,765.71 | 25.77 thousand | 20 |
| 325414 | BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING | 21,262.50 | 21.26 thousand | 12 |
Insight
Over the last 10 years, DMS PHARMACEUTICAL GROUP INC. (CAGE 1UNB0) has obligations concentrated in NAICS 424210, DRUGS AND DRUGGISTS' SUNDRIES MERCHANT WHOLESALERS, which accounts for $1.44 billion of the firm’s $1.87 billion total obligated amount. The next largest categories are 325411, MEDICINAL AND BOTANICAL MANUFACTURING, at $383.84 million, and 325412, PHARMACEUTICAL PREPARATION MANUFACTURING, at $35.83 million, indicating a clear skew toward pharmaceutical and related wholesale/manufacturing activity. Award volume is also heavily concentrated in 424210 and 325411, with 146,411 and 87,843 awards respectively, while the remaining NAICS codes contribute comparatively small obligated amounts.
Annual Trend
SELECT
year,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
toYear(parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate)) AS year,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '1UNB0'
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 10 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY year
)
ORDER BY year DESC| Year | Total Obligated | Readable | Award Actions |
|---|---|---|---|
| 2025 | 283,976,616.24 | 283.98 million | 39,489 |
| 2024 | 265,703,884.63 | 265.70 million | 37,207 |
| 2023 | 261,043,838.42 | 261.04 million | 41,843 |
| 2022 | 260,498,073.27 | 260.50 million | 40,486 |
| 2021 | 247,291,384.91 | 247.29 million | 42,007 |
| 2020 | 199,548,434.55 | 199.55 million | 34,299 |
| 2019 | 109,982,968.29 | 109.98 million | 27,627 |
| 2018 | 122,909,553.11 | 122.91 million | 24,834 |
| 2017 | 112,765,755.25 | 112.77 million | 17,872 |
| 2016 | 6,611,009.92 | 6.61 million | 51 |
Insight
Over the last 10 years, DMS PHARMACEUTICAL GROUP INC. (CAGE 1UNB0) recorded 1.87 billion in obligations across 305,715 awards, averaging 6,117.89 per award. Obligations are highly concentrated in the most recent five years, with annual funding between 199.55 million and 283.98 million from 2020 through 2025, compared with 6.61 million in 2016 and roughly 110 million to 123 million in 2017-2019. Award volume also increased materially over time, rising from 51 awards in 2016 to more than 39,000 annually in 2024-2025, indicating sustained high-frequency contracting activity.
Use FPDS Query for deeper contractor analysis
Explore federal procurement data with custom SQL, fast filtering, and deeper contractor analysis across buying agencies, NAICS, and annual trends.
Continue from this last 10 years view into full FPDS Query workflows with deeper filtering, custom SQL, saved queries, and broader market comparison.